Why the Cell Line Development Market Is Set To Explode? | Key Players are Selexis, Sartorius, Lonza Group, Samsung Biologics, WuXi AppTec, GE Healthcare, Sigma-Aldrich, GVK BIO

Graphical Research added research on cell line development market is a detailed analysis of this business space inclusive of the trends, competitive landscape, and the market size. Encompassing one or more parameters among product analysis, application potential, and the regional growth landscape, market also includes an in-depth study of the industry’s competitive scenario.

Chronic diseases like cancer are on the rise across different regions. There is a lot of research and development being done in order to reduce the increasing cases of these ailments. Cell therapy is another treatment that is generating a lot of awareness among the general public as there are a wide range of benefits attached to it. Governments across the world are making heavy investments in healthcare infrastructure to make sure the best facilities are being offered to those in need.

There is also rise in indulging in unhealthy eating and drinking habits like heavy indulgence in tobacco and alcohol. Sedentary lifestyle has taken the world by storm as well. All these factors have significantly contributed towards rise in various chronic diseases.

Some of the key trends that will stimulate demand for cell line development products are mentioned below:

New biologics demand will influence North America market:

Biologics are a form of drug that are manufactured using natural or biological resources. Neupogen, Lantus and Avonex were some of the most successful biologics in the industry. However, their expiring patents will give rise to the development of new ones.

Access sample pages of the report, “North America Cell Line Development Market Forecasts 2024” in detail along with the table of contents (ToC) @
https://www.graphicalresearch.com/request/1067/sample

These new products will help in boosting the forecast for cell line development market. In fact, the US FDA had approved 11 biologics in 2014 and 13 in 2015.

Role of monoclonal antibodies in the use of cell line development products:

North America is one of the leading countries when it comes to the number of chronic disease cases like cancer. In fact, it is one of the leading causes of death in the region. The regional institutions are carrying out intense research and development to find out ways to ease the burden of these chronic diseases by heavily investing in drugs discoveries and manufacturing vaccines.

Monoclonal antibodies are seeing a rapid rise in their demand because they require cell lines that are stable in nature to manufacture them. These are being used to treat various forms of autoimmune and anti-inflammatory diseases as well. All these factors will lead to growth of the regional cell line development market.

Reagents and media see considerable demand in the U.S.:

The reagents and media segment captured significant market share during 2017 in the U.S. market and is reported to go even higher in the coming years. The reason for this is being attributed to the wide range of applications this segment has to offer. Reagents can be used for various purposes like bio-production, tissue engineering, regenerative medicines, toxicity testing and many others.

The equipment used during cell culture experiments are experiencing technological advancements which will play a major role as well in the growth of cell line development industry in the region.

Europe to see higher demand for hybridomas cell line type:

The cell line development market is divided into different segments based on cell line types, like recombinant, continuous cell line, hybridomas and primary cell line segments. Out of these, the hybridomas cell line segment will gain momentum in demand across Europe. The major reason behind this is the increased production of monoclonal antibodies in the region. These antibodies help in combating various diseases and help in carrying out effective treatments for the patients as well.

Access sample pages of the report, “Europe Cell Line Development Market Forecasts 2024” in detail along with the table of contents (ToC) @
https://www.graphicalresearch.com/request/1066/sample

Potential of drug discovery segment in Europe market:

While analyzing the demand based on application, the cell line development sector is divided into bio-production, drug discovery, toxicity testing, tissue engineering and various other segments. Off these, the drug discovery segment is projected to show high growth potential in European market.

In fact, according to reports, this segment earned $106.6 million in revenue in 2017. This figure is predicted to go even higher, thanks to the increasing demand for new drugs for various chronic diseases like cancer. Fields like neurology and angiogenesis are increasingly demanding new drugs to find solutions to various disorders.

Toxicity testing will gain momentum in Asia Pacific region:

Toxicity testing segment under cell line development market will experience increase in demand in Asia Pacific. It is the process carried out by healthcare professionals to find out the level of toxic elements present in a particular drug and how safe it is for human consumption. Every drug that is newly discovered has this form of testing as one of its main parameters to determine whether it is fit for human consumption. The rise in demand for new drugs to combat various illnesses will result in increased demand for toxicity testing in the region.

Access sample pages of the report, “Asia Pacific Cell Line Development Market Forecasts 2024” in detail along with the table of contents (ToC) @
https://www.graphicalresearch.com/request/1065/sample

China will play an active role in cell line development market:

When it comes to demand for cell line development among different countries in Asia Pacific, the regional market boasts India, Korea, Japan, China, Australia and many others as its key participants. Out of these countries, China held significant market share in 2017 and this share is projected to increase even further in the coming years, according to experts.

Some of the major reasons attributed to this are the government policies supporting the growth of biopharmaceutical sector and rise in the magnitude of vaccine production and production of monoclonal antibodies in the country.

Some of the major companies dealing in global cell line development industry are GE Healthcare, Thermo Fisher Scientific, Sigma Aldrich Corporation (Merck), Lonza Group, Samsung Biologics, among others.

Contact Us:

Parikhit B.
Corporate Sales,
Graphical Research
Phone: 1-800-986-6917
Email: sales@graphicalresearch.com
Web: https://www.graphicalresearch.com

About Graphical Research:
Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.

This release was published on openPR.